PHIO

$1.27

Market ClosedAs of Mar 17, 8:00 PM UTC

Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPRO

Recent News

Associated Press Finance
Feb 10, 2026

BC-Most Active Stocks

CCH Holdings Ltd. 18,962,694 1.32

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MT Newswires
Dec 18, 2025

Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading

Asian equities traded in the US as American depositary receipts were sharply higher Thursday morning

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
MT Newswires
Jul 25, 2025

Phio Reports Tumor Responses in PH-762 Phase 1b Cancer Trial; Shares Surge

Phio Pharmaceuticals (PHIO) said Friday its experimental cancer therapy PH-762 showed a complete pat

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Zacks
May 28, 2025

Best Value Stocks to Buy for May 28th

PHIO, ALRS and URBN made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 28, 2025.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
May 28, 2025

New Strong Buy Stocks for May 28th

PHIO, FLNG, BWB, ALRS and HALO have been added to the Zacks Rank #1 (Strong Buy) List on May 28, 2025.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.